We are a research and development (R&D)-driven API manufacturer, focused on undertaking dedicated R&D in our existing products and in areas where we believe there is growth potential in the future. We believe that maintaining high standards of process innovation and quality in our R&D and manufacturing operations is critical to our brand and to developing long-term relationships with our customers.
The work we do spans the entire spectrum of the value chain, from research & development to scale up, manufacturing and delivery. Together, these help us support our customers all the way from product identification & development to commercialization and life cycle management.
We have steadily built scale in our product offerings and reach, leveraging state-of-the-art laboratories and manufacturing locations. GLS partners with 16 of the top 20 generic companies in the world (source: A Year of Surprises Shakes Up Off-Patent Industry" | Informa, 2020) and serves customers in multiple regions, including North America, Europe, Japan, Latin America, India and ROW.
We place strong emphasis on customer experience, and our local presence in markets like North America, United Kingdom and Latin America helps us understand customers' requirements.
From product selection & development to commercialization, we judiciously blend science, technology and economics to stay ahead of the curve. We cater to chronic therapeutic areas such as cardiovascular disease, central nervous system disorders, pain management and diabetes, among others.